Association of T869, C509T, G915C gene polymorphism of transforming growth factor-β1 with IgA nephropathy risk.

Tian-Biao Zhou,Xue-Feng Guo,Sheng-Sheng Yin
DOI: https://doi.org/10.3109/0886022X.2014.890059
IF: 3.222
2014-01-01
Renal Failure
Abstract:This meta-analysis was conducted to assess the association of transforming growth factor-β1 (TGF-β1) T869C, C509T, G915C gene polymorphism with the risk of IgA nephropathy (IgAN). The association literatures were identified from PubMed, Cochrane Library up to October 1, 2013, and eligible reports were recruited and synthesized. Five reports were recruited into this meta-analysis for the association of TGF-β1 T869C, C509T, G915C gene polymorphism with IgAN risk. In this meta-analysis, the association of TGF-β1 T869C, C509T, G915C gene polymorphism with IgAN risk was not found. In conclusion, TGF-β1 T869C, C509T, G915C gene polymorphism is not associated with the IgAN risk. However, more studies should be performed in the future to confirm this association.
What problem does this paper attempt to address?